Invention Grant
US09096669B2 Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) thereof and use of the same
有权
人源化抗TNF-α抗体及其抗原结合片段（Fab）及其用途
- Patent Title: Humanized anti-TNF-α antibody and antigen-binding fragment (Fab) thereof and use of the same
- Patent Title (中): 人源化抗TNF-α抗体及其抗原结合片段（Fab）及其用途
-
Application No.: US13876774Application Date: 2011-09-30
-
Publication No.: US09096669B2Publication Date: 2015-08-04
- Inventor: Xiao Ke , Xiaoping Gao
- Applicant: Xiao Ke , Xiaoping Gao
- Applicant Address: CN Sichuan
- Assignee: CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD.
- Current Assignee: CHENGDU KANGHONG BIOTECHNOLOGIES CO., LTD.
- Current Assignee Address: CN Sichuan
- Agency: Sutherland Asbill & Brennan LLP
- Priority: CN201010297255 20100930
- International Application: PCT/CN2011/001668 WO 20110930
- International Announcement: WO2012/041018 WO 20120405
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/00
Abstract:
The present invention discloses a humanized anti-human tumor necrosis factor-α antibody and antigen-binding fragment (Fab) thereof. The present invention also discloses a composition comprising the said antibody or antigen-binding fragment (Fab) thereof, and the use of the said antibody or antigen-binding fragment (Fab) thereof in treating the diseases associated with tumor necrosis factor-α.
Public/Granted literature
- US20140086904A1 Humanized Anti-TNF-alpha Antibody and Antigen-Binding Fragment (Fab) Thereof and Use of the Same Public/Granted day:2014-03-27
Information query
